- Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.
- Collaboration agreements for oncology candidates were signed between several major pharmaceutical companies.
A partnership involving Recursion Pharmaceuticals, Sanofi, Roche, Merck, and Relay Therapeutics diversifies pipelines across oncology and immunology, leveraging AI-driven platforms.
1 report, 1 independent
Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A partnership involving Recursion Pharmaceuticals, Sanofi, Roche, Merck, and Relay Therapeutics diversifies pipelines across oncology and immunology, leveraging AI-driven platforms.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Lunit and Discovery Life Sciences announced a strategic collaboration to expand AI adoption in life sciences.Sub-event
- Recursion Pharmaceuticals announced strategic alliances with Bayer, Sanofi, Roche, Merck, and Genentech.Sub-event
Collaboration between Recursion, Sanofi, Roche, Merck, and Relay on AI-driven oncology and immunology pipelines.1 source
Keep exploring
The entities involved
-
Relay Therapeutics
company in Cambridge, United States
Nothing else this week.
-
Hoffmann-La Roche
Swiss healthcare company
-
Sanofi
company in Milan, Italy
Nothing else this week.
-
Recursion (United States)
company in Salt Lake City, United States
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- ZacksCan Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? Recursion Pharmaceuticals RXRX is strategically leveraging its AI-powered drug discovery platform through multiple high-value col